February 1, 2023
FDA: Class I recall of Medtronic Mahurkar Acute Dual Lumen High Flow Hemodialysis Catheters
Editor's Note
The Food and Drug Administration (FDA) on January 30 identified the recall by Medtronic of its Mahurkar Acute Dual Lumen High Flow (13.5 French) Hemodialysis Catheters (Mahurkar QPlus) as Class I, the most serious.
The recall was initiated because of a potential catheter hub defect that may cause leaks across the catheter’s tubes.
There have been reports of two injuries and no deaths related to this issue.
Distribution dates were March 19, 2022, to September 2, 2022.
Free Daily News
- Assistance program leads to major drop in ER visits, costs for immigrants
- Anesthesia & Analgesia journal devotes October issue to DEI
- Long nursing shifts in mental health wards lead to increased patient incidents
- Closing keynote: Revolutionizing Healthcare with Artificial Intelligence (AI)—Reducing Administrative Burden and Improving Staff Satisfaction
- Postoperative session: PACU Boarding and Patient Experience—There are No Beds in the House!
- Leadership session: Empowering Your Team to Ensure Patient Safety
- ASC luncheon: Quality Measure Reporting Updates for ASCs
- Leadership session: Establishing an Environment of Continuous Improvement
- Business session: Profitability in the OR—Benchmark Your OR's Performance
- Leadership session: Managing Disruptive Behavior—A New Approach to Better Communication
- Pediatric Surgeon - Carilion Clinic - Roanoke, VA
- Vascular Surgeon Opportunity at Tertiary Care and Level II Trauma Center in Beautiful New England - Northern Light Eastern Maine Medical Center - Bangor, ME
- RN- Surgery (FT) $10,000 Hiring Incentives! - Spencer Hospital - Spencer, IA
- RN- Behavioral Health Services (FT) $10,000 Hiring Incentive! - Spencer Hospital - Spencer, IA
© Access Intelligence, LLC. All rights reserved. | Privacy Policy | Diversity Inclusion & Equity